Laser Study
The Lowy Medical Research Institute sponsored a pilot study to test subthreshold photothermal treatment in macular telangiectasia type 2. The purpose of this study, which employs a FDA approved laser system, is to induce a “healing” response in the treated portion of the macula. Participants were randomized to either treatment or sham (placebo) procedure, in one eye. The participants were followed for one year with a total of six visits.
The MacTel Laser Study is registered with clinicaltrials.gov, study ID NCT03321916
This study was conducted at the Medical College of Wisconsin. The Laser Study is completed.